Safety analysis showed that reducing the dose of MPH-LA from 80 mg/day to 20 mg/day, or suddenly stopping doses of 40, 60, or 80 mg/day had no impact on safety, indicating that the common practice of gradually tapering the dose of MPH-LA prior to discontinuation is unnecessary.
This model predicted that after stopping dosing at steady state, the average time to reach the lower limit of the normal ALC range (1.0 × 10·µL−1) is approximately 24 and 123 h (1 and 5.1 day) for the doses of 1 and 10 mg respectively.
Three levels of change on current prescription were defined as drug stopped, dose altered, and new drug started.
Open phase improvement was unlikely due to prophylactic treatment changes because in four out of six responders, this treatment was stopped, dose-decreased or unchanged.
Scientists have found that bacteria in a group of Canadian pigs remained mostly impervious to two antibiotics years after farmers stopped dosing the animals.
Likewise, close monitoring should be performed at the end of the season to note when it is appropriate to stop dosing.
(In September 2010, Roche decided to stop dosing patients in the taspoglutide phase 3 trials because higher than expected discontinuation rates of taspoglutide-treated patients were observed, mainly due to gastrointestinal tolerability and the implementation of the risk-mitigation plan to address serious hypersensitivity reactions.
All medications (prescription and over-the counter), vitamin and mineral supplements, and/or herbs taken by the participant are documented on the concomitant medication CRF and included: start and stop date, dose and route of administration, and indication for use.
Changes in mycophenolate dosage may be required in cases of concurrent cyclosporine starting, stopping, or dose changing [37].
